DNA-conjugated gold nanoparticles for ultrasound targeted drug delivery

Abstract

A novel platform based on gold nanoparticles (Au NPs) coupled with double-stranded DNA sequences and aptamers (referred to as ds(sgc8c)-Au NPs) was developed for ultrasoundcontrolled targeted drug delivery. The sgc8c aptamers with high affinity to CCRF-CEM (T-cell leukemia) cells facilitated the cellular uptake of ds(sgc8c)-Au NPs. The aptamers were extended with repeated CG base pairs for loading anticancer drugs doxorubicin (Dox). After incubated with ds(sgc8c)-Au NPs for 2 h, the cells were irradiated by 10-MHz high-intensity focused ultrasound (HIFU) at a focal spatial-average temporal-average intensity of 140 W/cm 2 for 10 min. It was found that the inertial cavitation induced by HIFU drove the specific release of Dox molecules from ds(sgc8c)-Au NPs as indicated by the increase in Dox fluorescence. The temperature within the focal volume only increased by 3°C during the irradiation, but reducing the gas content in the cell medium resulted in a 50% decrease in the fluorescence enhancement. This system can serve as a novel ultrasoundresponsive therapeutic system, showing great promise in targeted drug delivery for remote control of high spatial/temporal resolution as well as reductions in undesirable side effects.

Multivalent Sgc8c-aptamer decorated polymer scaffolds for leukemia targeting

“…[9][10][11] Besides a high specificity and affinity for PTK7 (K d = 0.8 nM), 5,12 sgc8c offers the advantage of being a small and easy to synthesize molecule. 13,14 New anti-T-ALL therapeutic tools include sgc8c-conjugated chemotherapy drugs, 15,16 and sgc8cdecorated platinum 17 and gold nanoparticles. 18 The potential disadvantages of these strategies include cellular toxicity to neighboring tissue after aptamer release.…”